Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys.
about
Suppression of IgE B cells and IgE binding to Fc(epsilon)RI by gene therapy with single-chain anti-IgE.Application of quantitative pharmacology in development of therapeutic monoclonal antibodiesUse of quantitative pharmacology in the development of HAE1, a high-affinity anti-IgE monoclonal antibody.Update on optimal use of omalizumab in management of asthma.Omalizumab: clinical use for the management of asthma.Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain.Pharmacokinetics and pharmacodynamics of rilotumumab: a decade of experience in preclinical and clinical cancer research.Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies.From IgE to Omalizumab.Current and future applications of the anti-IgE antibody omalizumab.Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodies.Preexisting Antibodies to an F(ab')2 Antibody Therapeutic and Novel Method for Immunogenicity Assessment.Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma.
P2860
Q33870977-808CE2CF-38F9-404F-AE2F-AF5BF1AAEC49Q34293689-F1AB7F21-9D0A-4794-9552-4A7468ED1741Q34805259-50391341-D643-44A0-B836-263D36834F88Q35117827-BD2AC964-32CB-43A0-9F87-589984B0CCDDQ36055963-B230BF36-539A-4F8F-AB03-3EF210EC14B3Q36706795-A56614BA-5226-4355-8BF7-97486470496AQ38442573-2926F56D-011F-4592-9380-0B8C95A2FFD4Q38747217-46BC2227-1556-46DF-82C2-8842A7023439Q38793428-7AC109B1-6AAC-4552-A7A0-31CBA1716EA6Q40119246-7DA2F479-5343-42F3-A0C8-4B7B7014A075Q41575242-92E440A7-BD1B-45AD-98B6-93BC8C530A7CQ42058488-04039DEB-5E38-4229-8827-9E224670F0EFQ42536548-63A74FF3-C787-4488-81C9-5EE0108DCE38
P2860
Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Tissue distribution and comple ...... tration in cynomolgus monkeys.
@en
Tissue distribution and comple ...... tration in cynomolgus monkeys.
@nl
type
label
Tissue distribution and comple ...... tration in cynomolgus monkeys.
@en
Tissue distribution and comple ...... tration in cynomolgus monkeys.
@nl
prefLabel
Tissue distribution and comple ...... tration in cynomolgus monkeys.
@en
Tissue distribution and comple ...... tration in cynomolgus monkeys.
@nl
P2093
P1476
Tissue distribution and comple ...... tration in cynomolgus monkeys.
@en
P2093
P304
P407
P577
1996-11-01T00:00:00Z